Diphtheria is an infectious disease prevented by vaccination. To ensure the
safety and immunogenicity of these vaccines, the regulatory entities demand in
vitro and in vivo techniques. In vitro techniques, such as ELISA, reduce the
number of animals, are more sensitive, faster and cheaper, then, currently work
is focused on its implementation. Therefore, the purpose of this work was to
develop a serological assay, ELISA in curiel, that allow the determination of the
immunogenic activity of this type of vaccines. The batches of reference
materials (RM) were prepared: Diphtheria coating toxoid, curiel serum,
calibration curve and positive control. The optimal conditions of the assay were
established, the interval and linearity of the curve were defined, as well as the
intra- and inter-assay precision and the specificity. The results of the serological
test, ELISA in curiel, and the in vivo seroneutralization test dose were
compared. The calibration curve was generated with a standard serum and a
good linear adjustment was achieved with a R2 ≥ 0,98; stablishing 10Lf/mL as
the optimal coating concentration, 1/12000 as the dilution of conjugate and an
incubation temperature of 37ºC. The variation coefficients in the intra- and inter
assay precision tests in the intervals established for each one were ≤ 10% and
≤ 20% respectively, showing an adequate correlation between both tests. The
results obtained endorse the employment of this quantitative ELISA for the
evaluation of the immunogenic activity of antidiphtheric vaccines.